DK3453046T3 - Glutaratforbindelser til behandling af iskæmi-reperfusionslæsioner - Google Patents
Glutaratforbindelser til behandling af iskæmi-reperfusionslæsionerInfo
- Publication number
- DK3453046T3 DK3453046T3 DK17793057.5T DK17793057T DK3453046T3 DK 3453046 T3 DK3453046 T3 DK 3453046T3 DK 17793057 T DK17793057 T DK 17793057T DK 3453046 T3 DK3453046 T3 DK 3453046T3
- Authority
- DK
- Denmark
- Prior art keywords
- ischemia
- treatment
- reperfusion lesions
- glutarate compounds
- glutarate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662330178P | 2016-05-01 | 2016-05-01 | |
| PCT/US2017/030320 WO2017192413A1 (en) | 2016-05-01 | 2017-04-30 | Glutarate compounds for treating ischemia-reperfusion injuries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3453046T3 true DK3453046T3 (da) | 2025-10-13 |
Family
ID=60203313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17793057.5T DK3453046T3 (da) | 2016-05-01 | 2017-04-30 | Glutaratforbindelser til behandling af iskæmi-reperfusionslæsioner |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10285962B2 (da) |
| EP (1) | EP3453046B1 (da) |
| CN (1) | CN109417016B (da) |
| DK (1) | DK3453046T3 (da) |
| ES (1) | ES3048139T3 (da) |
| TW (1) | TWI801337B (da) |
| WO (1) | WO2017192413A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10285962B2 (en) * | 2016-05-01 | 2019-05-14 | The Regents Of The University Of California | Glutarate compounds for treating ischemia-reperfusion injuries |
| CN109682894A (zh) * | 2018-12-13 | 2019-04-26 | 南通市产品质量监督检验所 | 一种饮料中索马甜的检测方法 |
| GB201918022D0 (en) * | 2019-12-09 | 2020-01-22 | Cambridge Entpr Ltd | Treatment or prevention of Ischaemic Stroke Reperfusion Injury |
| CN114028371A (zh) * | 2021-12-10 | 2022-02-11 | 中国人民解放军陆军特色医学中心 | α-酮戊二酸在制备治疗心肌梗死的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9402027D0 (sv) * | 1994-06-10 | 1994-06-10 | Pharmacia Ab | Energy substrates |
| DE10222561B4 (de) | 2002-05-17 | 2009-12-10 | Dr. Franz Köhler Chemie GmbH | Protektive Lösung zur Verhinderung von Ischämieschäden |
| CN101579332A (zh) * | 2008-05-13 | 2009-11-18 | 北京嘉事联博医药科技有限公司 | 一种治疗心血管疾病的药物组合物及其用途 |
| CN101579331A (zh) | 2008-05-13 | 2009-11-18 | 北京嘉事联博医药科技有限公司 | α-酮戊二酸镁在制备抗心脑缺血疾病药物中的应用 |
| US10285962B2 (en) * | 2016-05-01 | 2019-05-14 | The Regents Of The University Of California | Glutarate compounds for treating ischemia-reperfusion injuries |
-
2017
- 2017-04-30 US US15/582,748 patent/US10285962B2/en active Active
- 2017-04-30 ES ES17793057T patent/ES3048139T3/es active Active
- 2017-04-30 EP EP17793057.5A patent/EP3453046B1/en active Active
- 2017-04-30 DK DK17793057.5T patent/DK3453046T3/da active
- 2017-04-30 CN CN201780037907.7A patent/CN109417016B/zh active Active
- 2017-04-30 WO PCT/US2017/030320 patent/WO2017192413A1/en not_active Ceased
- 2017-05-01 TW TW106114409A patent/TWI801337B/zh active
-
2019
- 2019-03-09 US US16/297,599 patent/US10500177B2/en active Active
- 2019-11-04 US US16/673,081 patent/US11007163B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190201357A1 (en) | 2019-07-04 |
| EP3453046B1 (en) | 2025-07-09 |
| TW201806590A (zh) | 2018-03-01 |
| US20170333373A1 (en) | 2017-11-23 |
| US20200069621A1 (en) | 2020-03-05 |
| TWI801337B (zh) | 2023-05-11 |
| ES3048139T3 (en) | 2025-12-09 |
| US10500177B2 (en) | 2019-12-10 |
| US10285962B2 (en) | 2019-05-14 |
| CN109417016B (zh) | 2022-06-03 |
| EP3453046A4 (en) | 2020-01-08 |
| CN109417016A (zh) | 2019-03-01 |
| US11007163B2 (en) | 2021-05-18 |
| EP3453046A1 (en) | 2019-03-13 |
| WO2017192413A1 (en) | 2017-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3728271T3 (da) | Makrocykliske forbindelser til behandling af sygdomme | |
| DK3245206T3 (da) | Pyrazinforbindelser til behandling af infektionssygdomme | |
| DK3501542T3 (da) | Esketamin til behandling af depression | |
| DK3439635T3 (da) | Formuleringer til behandling af fast tumor | |
| DK3173092T3 (da) | Rna-holdig sammensætning til behandling af tumorsygdomme | |
| DK3377516T3 (da) | Sammensætning til behandling af cancer | |
| IL264143B (en) | Processes for preparing olaparib | |
| DK3383363T3 (da) | Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande | |
| DK3189082T3 (da) | Anti-pd-l1-konjugater til behandling af tumorer | |
| DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
| DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
| DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
| EP3509581A4 (en) | FORMULATIONS OF (R | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
| DK3524255T3 (da) | Sammensætning til behandling af acne | |
| DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| EP3995139C0 (en) | COMPOSITION FOR USE IN CANCER TREATMENT | |
| HUE058257T2 (hu) | Eljárások oxatiazin-jellegû vegyületek elõállítására | |
| DK3400072T3 (da) | Formuleringer til behandling af blærecancer | |
| DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
| DK3166611T3 (da) | Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme |